68 related articles for article (PubMed ID: 6388828)
1. Transfer of age-associated restrained tumor growth in mice by old-to-young bone marrow transplantation.
Ershler WB; Moore AL; Shore H; Gamelli RL
Cancer Res; 1984 Dec; 44(12 Pt 1):5677-80. PubMed ID: 6388828
[TBL] [Abstract][Full Text] [Related]
2. Hormonal influences on growth of B16 murine melanoma.
Simon SR; Ershler WB
J Natl Cancer Inst; 1985 May; 74(5):1085-8. PubMed ID: 3858578
[TBL] [Abstract][Full Text] [Related]
3. Role of the thymus and T-cells in slow growth of B16 melanoma in old mice.
Tsuda T; Kim YT; Siskind GW; DeBlasio A; Schwab R; Ershler W; Weksler ME
Cancer Res; 1987 Jun; 47(12):3097-100. PubMed ID: 3495326
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
[TBL] [Abstract][Full Text] [Related]
5. Effect of host age on the transplantation, growth, and radiation response of EMT6 tumors.
Rockwell S
Cancer Res; 1981 Feb; 41(2):527-31. PubMed ID: 7448800
[TBL] [Abstract][Full Text] [Related]
6. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice.
Pearlstein E; Ambrogio C; Karpatkin S
Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304
[TBL] [Abstract][Full Text] [Related]
7. Enhanced graft-versus-host disease in older recipient mice following allogeneic bone marrow transplantation.
Bryson JS; Jennings CD; Caywood BE; Dix AR; Lowery DM; Kaplan AM
Bone Marrow Transplant; 1997 Apr; 19(7):721-8. PubMed ID: 9156250
[TBL] [Abstract][Full Text] [Related]
8. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
LeGrue SJ; Hearn DR
Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
[TBL] [Abstract][Full Text] [Related]
9. [Effect of age on the growth of transplantable tumors in mice].
Anisimov VN; Zhukovskaia NV
Vopr Onkol; 1981; 27(8):52-9. PubMed ID: 7281593
[TBL] [Abstract][Full Text] [Related]
10. Murine tyrosinase expressed by a T7 vector in bone marrow-derived dendritic progenitors effectively prevents and eradicates melanoma tumors in mice.
Li J; Holmes LM; Franek KJ; Wagner TE; Wei Y
Cancer Gene Ther; 2000 Nov; 7(11):1448-55. PubMed ID: 11129287
[TBL] [Abstract][Full Text] [Related]
11. Decreased DNA ploidy may constitute a mechanism of the reduced malignant behavior of B16 melanoma in aged mice.
Itzhaki O; Skutelsky E; Kaptzan T; Siegal A; Sinai J; Schiby G; Michowitz M; Huszar M; Leibovici J
Exp Gerontol; 2008 Mar; 43(3):164-75. PubMed ID: 18261868
[TBL] [Abstract][Full Text] [Related]
12. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
[TBL] [Abstract][Full Text] [Related]
14. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
[TBL] [Abstract][Full Text] [Related]
15. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
[TBL] [Abstract][Full Text] [Related]
16. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
17. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
Suzuki Y; Adachi Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Ikehara S
Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
19. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
20. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
